Weight loss drugs

The emergence of GLP-1 weight loss drugs like Ozempic and Mounjaro marks a significant shift in managing obesity, a condition affecting approximately 65% of British adults. Originally developed to treat diabetes by mimicking natural hormones that signal fullness, these medications are now frequently prescribed "off-label" for weight management. Patient testimony from Lynn Massey-Davis highlights how the treatment eliminates "food noise"—the intrusive, persistent thoughts about eating—and resolves the psychological "angel and devil" dilemma that often damages self-esteem. While Professor Giles Yeo notes that weight loss was initially discovered as a side effect of blood sugar regulation, medical experts emphasize that these injections should complement, rather than replace, healthy lifestyle choices. Despite their efficacy in helping patients lose significant weight, such as Massey-Davis’s 20-kilogram reduction, public health officials maintain that long-term health requires a holistic approach beyond pharmaceutical intervention.